Development of Halal modified release gliclazide 60 mg tablets by central composite design and production by direct compression
Background: Gliclazide is a second generation sulphonylurea drug used for the treatment of type 2 diabetes mellitus. Commercially available modified release (MR) gliclazide tablet is a once-daily formulation that employs a hydrophilic matrix of a hypromellose for drug release retardant activity. It...
| Main Authors: | , , |
|---|---|
| Format: | Conference or Workshop Item |
| Language: | English |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/38282/ http://irep.iium.edu.my/38282/ http://irep.iium.edu.my/38282/1/ICIP_2014.pdf |